Test: African Horse Sickness (AHS)  - Ab cELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)      Test method

AHS (ELISA) - CVRLSR 006 - Module 4

b)     Test type

Qualitative

c)      Sample matrix

Serum Samples

d)     Sample Volume/Amount

5 - 7ml Serum

e)     Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)       TAT

4 - 5 working days

g)      Results

Refer ‘CVRL- Guidelines

h)     Measurement of Uncertainty (MU)

N/A

i)       Expression of result

Positive or Negative

Test: Dourine - Complement fixation test (CFT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Dourine (CFT) - CVRLSR 005-Module1 (OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.5.3)

b)   Test type

Quantitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 -7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

j)     Cut off titres

Negative: ≤ 1:5+

Positive : ≥ 1:5++

Test: Equine Infectious Anaemia (EIA) - Agar Gel Immunodiffusion test (AGID/Coggins)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

EIA (AGID) - CVRLSR 007-Module1

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

Test: EIA - Ab cELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

EIA (ELISA) - CVRLSR 006 - Module 8

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

Test: Equine Herpes Virus 1& 4 (EHV1 & EHV4) - Ab ELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

EHV1 and EHV4 (ELISA) - CVRLSR 006 - Module 3

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative ,Dubious or Positive

Test: Equine Piroplasmosis (Babesia caballi + Theileria equi ) - Ab cELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

T. equi (ELISA) - CVRLSR 006 - Module 6

B.caballi (ELISA) - CVRLSR 006 - Module 7

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

Test: Glanders - Complement fixation test (CFT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Glanders (CFT) - CVRLSR 005-Module2 (OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.5.11)

b)   Test type

Quantitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Inconclusive or Positive

j)     Cut off titres

Negative: ≤ 1:5++

Inconclusive: 1:5+++

Positive : ≥ 1:5++++

Test: Strangles (A + C antigen) - Ab ELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Strangles (ELISA) - CVRLSR 006 - Module 2

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Grey area or Positive

j)     Cut off titres

Negative: ≤ 0.2

Grey area: > 0.2 and < 0.5

Positive : ≥ 0.5

Test: West Nile Fever - IgG Ab ELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

West Nile (cELISA) - CVRLSR 006 - Module 5

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Dubious or Positive

Test: West Nile Fever - IgM Ab ELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

West Nile IgM (ELISA) - CVRLSR 006 - Module 1

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Dubious or Positive

Test: Brucellosis - Rose Bengal test  (RBT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Brucellosis (RBT) - OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

5 - 7ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

Test: Brucellosis - Serum agglutination test (SAT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Brucellosis (SAT) - OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4

b)   Test type

Quantitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

2 - 3ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

j)     Cut off titres

Negative: < 1:20++

Positive : ≥ 1:20++

Test: Brucellosis - Ab cELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Brucellosis (ELISA) - Ingezim Brucella Compac 2.0

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

2 - 3ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative or Positive

Test: Brucellosis - Complement fixation test (CFT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

Brucellosis (CFT) - OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4

b)   Test type

Quantitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

2 - 3ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Inconclusive or Positive

j)     Cut off titres

Negative: < 1:2+++

Inconclusive: 1:2+++ to 1:4+

Positive : ≥ 1:4++

Test: MERS-CoV in camels - Ab ELISA

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications:

 

a)    Test method

MERS CoV (ELISA) - CVRLSR 006 - Module 10

b)   Test type

Qualitative

c)    Sample matrix

Serum Samples

d)   Sample Volume/Amount

2 - 3ml Serum

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines

f)     TAT

4 - 5 working days

g)    Results

Refer ‘CVRL- Guidelines

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Negative, Inconclusive or Positive

 

© 2018 CVRL | Powered by whyIT Solutions